Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Bhattacharyya, Sanjib ^a   Saha, Sounik ^b   Giri, Karuna ^a   Lanza, Ian R ^c   Nair, K Sreekumar ^c   Jennings, Nicholas B ^d   Rodriguez Aguayo, Cristian ^d   Lopez Berestein, Gabriel ^d   Basal, Eati ^c   Weaver, Amy L ^c   Visscher, Daniel W ^c   Cliby, William ^c   Sood, Anil K ^d   Bhattacharya, Resham ^b   Mukherjee, Priyabrata ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c MAYO CLINIC ROCHESTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATALASE; CISPLATIN; CITRATE SYNTHASE; CYSTATHIONINE BETA SYNTHASE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE;

ADULT; ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MIDDLE AGED; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OVARY CANCER; OXIDATION REDUCTION REACTION; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TISSUE DISTRIBUTION; TISSUE MICROARRAY; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; CYSTATHIONINE BETA-SYNTHASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MIDDLE AGED; MITOCHONDRIA; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHENOTYPE; TUMOR BURDEN; YOUNG ADULT;

EID: 84893386128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079167     Document Type: Article

References (50)

1. Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6(11): 917-35.
2. Paul BD, Snyder SH (2012) H(2)S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 13(8): 499-507.
3. Martelli A, Testai L, Marino A, Breschi MC, Da Settimo F, et al. (2012) Hydrogen sulphide: biopharmacological roles in the cardiovascular system and pharmaceutical perspectives. Curr Med Chem 19(20): 3325-36.
4. Vandiver M, Snyder SH (2012) Hydrogen sulfide: a gasotransmitter of clinical relevance. J Mol Med (Berl) 90(3): 255-63.
5. Xiao L, Lan A, Mo L, Xu W, Jiang N, et al. (2012) Hydrogen sulfide protects PC12 cells against reactive oxygen species and extracellular signal-regulated kinase 1/2-mediated downregulation of glutamate transporter-1 expression induced by chemical hypoxia. Int J Mol Med 30(5): 1126-32.
6. Wang R (2012) Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed. Physiol Rev 92(2): 791-896.
7. Blackstone E, Morrison M, Roth MB (2005) H2S induces a suspended animation-like state in mice. Science 308(5721): 518. (Pubitemid 40570576)
8. Shatalin K, Shatalina E, Mironov A, Nudler E (2011) H2S: a universal defense against antibiotics in bacteria. Science 334(6058): 986-90.
9. Fiorucci S, Distrutti E, Cirino G, Wallace JL (2006) The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 131(1): 259-71. (Pubitemid 44043128)
10. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, et al. (1995) Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U.S.A. 92(5): 1585-9.
11. Beard RS, Jr., Bearden SE (2011) Vascular complications of cystathionine beta-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 300(1): H13-26.
12. Dayal S, Chauhan AK, Jensen M, Leo L, Lynch CM, et al. (2012) Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia. Blood 119(13): 3176-83.
13. Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, et al. (2008) B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci USA. 2008;105(34): 12474-9.
14. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354(15): 1578-88.
15. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, et al. (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Jama 300(7): 795-804.
16. Agarwal R, Kaye SB (2003) Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 3(7): 502-16. (Pubitemid 37328838)
17. Yin F, Liu X, Li D, Wang Q, Zhang W, et al. (2013) Tumor suppressor genes associated with drug resistance in ovarian cancer. Oncol Rep 30(1): 3-10.
18. Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, et al. (2009) Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clin Cancer Res 2009;15(11): 3770-80.
19. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, et al. (2008) Role of hedgehog signaling in ovarian cancer. Clin Cancer Res 14(23): 7659-66.
20. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6): 1101-8. (Pubitemid 351818697)
21. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, et al. (2005) Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11(9): 3530-4. (Pubitemid 40627908)
22. Hung YP, Albeck JG, Tantama M, Yellen G (2011) Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor. Cell Metab (4): 545-54.
23. Chompoosor A, Saha K, Ghosh PS, Macarthy DJ, Miranda OR, et al. (2010) The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. Small 6(20): 2246-9.
24. Hutter E, Renner K, Pfister G, Stockl P, Jansen-Durr P, et al. (2004) Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts. Biochem J 380(Pt 3): 919-28. (Pubitemid 38850535)
25. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, et al. (2007) Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2(9): 2295-301. (Pubitemid 351565867)
26. Rooyackers OE, Adey DB, Ades PA, Nair KS (1996) Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci USA 93(26): 15364-9. (Pubitemid 27009606)
27. Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, et al. (2008) Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst 100(5): 359-72. (Pubitemid 351480526)
28. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324(5933): 1457-61.
29. Bao L, Vlcek C, Paces V, Kraus JP (1998) Identification and tissue distribution of human cystathionine beta-synthase mRNA isoforms. Arch Biochem Biophys 350(1): 95-103. (Pubitemid 28371173)
30. Guzman MA, Navarro MA, Carnicer R, Sarria AJ, Acin S, et al. (2006) Cystathionine beta-synthase is essential for female reproductive function. Hum Mol Genet 15(21): 3168-76. (Pubitemid 44605497)
31. Ludwig ML, Matthews RG (1997) Structure-based perspectives on B12-dependent enzymes. Annu Rev Biochem 6: 269-313.
32. Caliendo G, Cirino G, Santagada V, Wallace JL (2010) Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 53(17): 6275-86.
33. Predmore BL, Lefer DJ (2010) Development of hydrogen sulfide-based therapeutics for cardiovascular disease. J Cardiovasc Transl Res 3(5): 487-98.
34. Vousden KH, Ryan KM (2009) p53 and metabolism. Nat Rev Cancer 9(10): 691-700.
35. Lotem J, Peled-Kamar M, Groner Y, Sachs L (1996) Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc Natl Acad Sci USA 93(17): 9166-71. (Pubitemid 26282036)
36. Papa S, Bubici C, Pham CG, Zazzeroni F, Franzoso G (2005) NF-kappaB meets ROS: an 'iron-ic' encounter. Cell Death Differ 12(10): 1259-62. (Pubitemid 41486096)
37. Stein SJ, Baldwin AS (2011) NF-kappaB suppresses ROS levels in BCR-ABL(+) cells to prevent activation of JNK and cell death. Oncogene 30(45): 4557-66.
38. Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21(1): 103-15.
39. Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, et al. (2011) Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One 6(3): e17918.
40. Lanza IR, Nair KS (2009) Functional assessment of isolated mitochondria in vitro. Methods Enzymol 457: 349-72.
41. Fu M, Zhang W, Wu L, Yang G, Li H, et al. (2012) Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci USA 109(8): 2943-8.
42. Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22(47): 7369-75.
43. Singh S, Khan AR, Gupta AK (2012) Role of glutathione in cancer pathophysiology and therapeutic interventions. J Exp Ther Oncol 9(4): 303-16.
44. Laborde E (2010) Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 17(9): 1373-80.
45. Backos DS, Franklin CC, Reigan P (2012) The role of glutathione in brain tumor drug resistance. Biochem Pharmacol 83(8): 1005-12.
46. Szabo C, Coletta C, Chao C, Módis K, Szczesny B, et al. (2013) Tumor-derived hydrogen sulfide, produced by cystathionine-b-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci USA 110(30): 12474-9.
47. Choi BK, Choi CH, Oh HL, Kim YK (2004) Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology 25(6): 915-24. (Pubitemid 39335584)
48. Lou H, Kaplowitz N (2007) Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms. J Biol Chem 282(40): 29470-81. (Pubitemid 350043388)
49. Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, et al. (2004) Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279(22): 23477-85. (Pubitemid 38685659)
50. Desaint S, Luriau S, Aude JC, Rousselet G, Toledano MB (2004) Mammalian antioxidant defenses are not inducible by H2O2. J Biol Chem 279(30): 31157-63. (Pubitemid 39037778)